A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects.
暂无分享,去创建一个
J. Weber | B. Peters | G. Patou | R. Foxall | J. Weber | R. Cheingsong-Popov | D. Callow | K. Hodgkin
暂无分享,去创建一个
J. Weber | B. Peters | G. Patou | R. Foxall | J. Weber | R. Cheingsong-Popov | D. Callow | K. Hodgkin